Canine and murine models of osteosarcoma

Vet Pathol. 2022 May;59(3):399-414. doi: 10.1177/03009858221083038. Epub 2022 Mar 26.

Abstract

Osteosarcoma (OS) is the most common malignant bone tumor in children. Despite efforts to develop and implement new therapies, patient outcomes have not measurably improved since the 1980s. Metastasis continues to be the main source of patient mortality, with 30% of cases developing metastatic disease within 5 years of diagnosis. Research models are critical in the advancement of cancer research and include a variety of species. For example, xenograft and patient-derived xenograft (PDX) mouse models provide opportunities to study human tumor cells in vivo while transgenic models have offered significant insight into the molecular mechanisms underlying OS development. A growing recognition of naturally occurring cancers in companion species has led to new insights into how veterinary patients can contribute to studies of cancer biology and drug development. The study of canine cases, including the use of diagnostic tissue archives and clinical trials, offers a potential mechanism to further canine and human cancer research. Advancement in the field of OS research requires continued development and appropriate use of animal models. In this review, animal models of OS are described with a focus on the mouse and tumor-bearing pet dog as parallel and complementary models of human OS.

Keywords: canine; comparative oncology; dogs; experimental animal models; metastasis; mice; murine models; osteosarcoma; review; veterinary clinical trials.

Publication types

  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural

MeSH terms

  • Animals
  • Bone Neoplasms* / pathology
  • Bone Neoplasms* / veterinary
  • Disease Models, Animal
  • Dog Diseases* / therapy
  • Dogs
  • Humans
  • Mice
  • Osteosarcoma* / pathology
  • Osteosarcoma* / veterinary